CellScape Corp. has raised $9.3 million in funding, according to a regulatory filing with the U.S. Securities and Exchange Commission on Friday.
The Mountain View-based company, formerly known as Saryna Medical Corp., sold equity to raise the funds. The company specializes in first trimester, non-invasive, fetal genetic testing, according to its profile on LinkedIn.
The related parties listed on the filing include: Karen Drexler, David Hanzel, Peter Kolchinsky and Bhairavi Parikh.
